News Updates
More Articles
- Cholera vaccine shortage likely to persist for 18 months
- NICE backs Bayer's darolutamide combo for metastatic prostate cancer
- Ironwood Pharma to purchase VectivBio for $1B
- IVI, Nankai team up for vaccine research, development
- Astellas, Sony to collaborate on antibody-drug conjugate
Astellas, Sony to collaborate on antibody-drug conjugate
Astellas Pharma has partnered with Sony for the development of a platform for a novel antibody-drug conjugate for cancer therapeutics. Sony's biotech R&D arm and Astellas will leverage Kiravia Backbone, a novel polymeric material, which will act as a linker for the novel ADC. BioSpace (San Francisco) (5/16)
Read full article now.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!